New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.

[1]  R. Franco,et al.  Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[2]  I. Fidler,et al.  Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse. , 2011, International immunopharmacology.

[3]  K. Aozasa,et al.  Infiltration of tumour‐associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer , 2011, BJU international.

[4]  M. Marra,et al.  Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. , 2011, International journal of pharmaceutics.

[5]  G. De Rosa,et al.  Oligonucleotide delivery in cancer therapy , 2010, Expert opinion on drug delivery.

[6]  Vassiliki Tzelepi,et al.  Therapeutic targeting of the prostate cancer microenvironment , 2010, Nature Reviews Urology.

[7]  E. Heath,et al.  Angiogenesis inhibitors in the treatment of prostate cancer , 2010, Journal of hematology & oncology.

[8]  P. Saylor,et al.  Bone health and prostate cancer , 2010, Prostate Cancer and Prostatic Diseases.

[9]  G. Botti,et al.  Zoledronic acid: an unending tale for an antiresorptive agent , 2010, Expert opinion on pharmacotherapy.

[10]  I. Hussain,et al.  Adult B lymphoblastic leukaemia/lymphoma with hypodiploidy (-9) and a novel chromosomal translocation t(7;12)(q22;p13) presenting with severe eosinophilia – case report and review of literature , 2009, Journal of hematology & oncology.

[11]  G. Kuttan,et al.  Role of macrophages in tumour progression. , 2009, Immunology letters.

[12]  K. Cullen,et al.  Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate‐associated osteonecrosis , 2009, British journal of haematology.

[13]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[14]  P. Clézardin,et al.  Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo. , 2008, Cancer research.

[15]  M. Caraglia,et al.  Repeated Intermittent Low-Dose Therapy with Zoledronic Acid Induces an Early, Sustained, and Long-Lasting Decrease of Peripheral Vascular Endothelial Growth Factor Levels in Cancer Patients , 2007, Clinical Cancer Research.

[16]  P. Clézardin,et al.  Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. , 2007, Journal of the National Cancer Institute.

[17]  M. Marra,et al.  Emerging anti-cancer molecular mechanisms of aminobisphosphonates. , 2006, Endocrine-related cancer.

[18]  J. Fagin.  Welcome from the new Editor-in-Chief , 2006 .

[19]  L. Yahia,et al.  Therapeutic potential of nanoparticulate systems for macrophage targeting. , 2005, Biomaterials.

[20]  A. Maitra.  Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy , 2005, Expert review of molecular diagnostics.

[21]  B. Vincenzi,et al.  Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[22]  Janet E Brown,et al.  The role of bisphosphonates in breast and prostate cancers. , 2004, Endocrine-related cancer.

[23]  C. Riebeling,et al.  The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro , 2002, British Journal of Cancer.

[24]  W. Winkelmann,et al.  The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro , 2001, Anti-cancer drugs.

[25]  P. Choong,et al.  Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line , 2001, British Journal of Cancer.

[26]  F. Singer,et al.  Bisphosphonate treatment inhibits the growth of prostate cancer cells. , 2001, Cancer research.

[27]  J. Zhang,et al.  Effect of pH, ionic strength and oxygen burden on the chemical stability of EPC/cholesterol liposomes under accelerated conditions. Part 1: Lipid hydrolysis. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  G. Pirianov,et al.  Bisphosphonates induce apoptosis in human breast cancer cell lines , 2000, British Journal of Cancer.

[29]  P. Croucher,et al.  Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity , 1997, British journal of haematology.

[30]  F. Szoka,et al.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.